GE HealthCare Technologies (GEHC) is back in focus after showcasing a broad set of imaging agents, AI-enabled software and PET or SPECT/CT systems aimed at precision care across cardiology, neurology and oncology.

Despite the recent product showcase, GE HealthCare’s share price has been under pressure, with the stock down 21.55% on a 90 day share price return and the 1 year total shareholder return declining 12.73%. This suggests momentum has been fading even as new imaging and AI tools come through.

If GE HealthCare’s push into healthcare AI has caught your eye, it can be useful to see what else is happening in the space by scanning 39 healthcare AI stocks

With GE HealthCare’s shares under pressure despite new products and reported annual revenue and net income growth, the key question now is whether the current valuation underestimates its healthcare AI ambitions or whether the market is already pricing in future growth.

Most Popular Narrative: 4.6% Undervalued

Against a last close of $61.99, the most followed narrative sees fair value closer to $65, framing GE HealthCare as modestly undervalued on cautious assumptions.

While the company is bringing a broad wave of new CT and MR systems to market, the long lag between regulatory clearance, order conversion and site readiness means much of the expected revenue is pushed into 2027 and beyond. This can constrain near term revenue growth and delay earnings contribution from higher margin systems.

Read the complete narrative. Read the complete narrative.

Want to see what sits behind that cautious fair value uplift? The narrative leans on measured revenue growth, firmer margins and a future earnings multiple below many peers. The tension is in how those pieces interact to justify a higher price than today.

Result: Fair Value of $65 (UNDERVALUED)

However, there are still clear swing factors, including faster uptake of new CT or MR platforms and a stronger ramp in radiopharmaceuticals, which could potentially challenge that cautious setup.

Next Steps

Given the mix of concern and optimism running through this story, it makes sense to look at the underlying data yourself and decide how you feel about the balance. To see that blend set out clearly, review the 4 key rewards and 1 important warning sign

Looking for more investment ideas?

If GE HealthCare has sparked your interest, do not stop here; broaden your watchlist with other focused stock ideas that could suit different goals and risk levels.

• Target stronger value opportunities by scanning companies that screen as 47 high quality undervalued stocks based on their fundamentals and current pricing.
• Prioritize resilience by checking out 63 resilient stocks with low risk scores so you can focus on companies with more contained risk profiles.
• Hunt for less crowded opportunities by using the screener containing 22 high quality undiscovered gems that may not yet sit on every investor's radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.